NEW YORK , June 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sable Offshore Corp. ("Sable" or the "Company") (NYSE: SOC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sage Therapeutics, Inc. ("Sage" or "the Company") (NASDAQ:SAGE). Investors who purchased Sage securities prior to April 12, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SAGE.

NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flux Power Holdings, Inc. ("Flux" or "the Company") (NASDAQ:FLUX). Investors who purchased Flux securities prior to November 11, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FLUX.

NEW YORK, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Abacus Global Management, Inc. ("Abacus" or "the Company") (NASDAQ:ABL). Investors who purchased Abacus securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ABL.

NEW YORK , June 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Reddit, Inc. ("Reddit" or "the Company") (NYSE:RDDT). Investors who purchased Reddit securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/RDDT.

NEW YORK , June 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Vera Bradley, Inc. ("Vera Bradley" or the "Company") (NASDAQ: VRA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , June 17, 2025 /PRNewswire/ --Pomerantz LLP is investigating claims on behalf of investors of Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ: QIPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cummins Inc. ("Cummins" or "the Company") (NYSE:CMI). Investors who purchased Cummins securities prior to April 30, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CMI.

NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Equinix, Inc. ("Equinix" or "the Company") (NASDAQ:EQIX). Investors who purchased Equinix securities prior to May 3, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/EQIX.

NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Customers Bancorp, Inc. ("Customers Bancorp" or "the Company") (NYSE:CUBI). Investors who purchased Customers Bancorp securities prior to March 1, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CUBI.

NEW YORK , June 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE: GMED). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , June 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Metallus Inc. ("Metallus" or the "Company") (NYSE: MTUS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

New geopolitical conflicts in the Middle East have created a new wave of uncertainty and volatility in the S&P 500 index and the rest of the global markets. However, one specific market has become the poster child of all this uncertainty, and that is the energy sector, particularly regarding oil prices.

T-Mobile US Inc (NASDAQ:TMUS, ETR:TM5) shares fell 4.5% on Tuesday morning after SoftBank Group Corp sold 21.5 million shares in the wireless carrier through a $4.9 billion overnight block trade, trimming its stake from 7.5% to 5.6%. The unregistered sale, priced between $224 and $228 per share, represented a discount of about 3% to Monday's closing price and marks the biggest US equity block sale since Toronto-Dominion Bank's $13.1 billion divestiture of Charles Schwab in 2023.

INDIANA, Pa., June 17, 2025 /PRNewswire/ -- S&T Bank, the wholly owned subsidiary of S&T Bancorp Inc. (NASDAQ, STBA), is announcing a 2025 donation of over $117,000 to Alex's Lemonade Stand Foundation (ALSF).

Jabil (JBL) came out with quarterly earnings of $2.55 per share, beating the Zacks Consensus Estimate of $2.33 per share. This compares to earnings of $1.89 per share a year ago.

NEW YORK, NY / ACCESS Newswire / June 17, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=153456&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

Biotech stock Verve Therapeutics Inc (NASDAQ:VERV) is up 75.3% to trade at $10.99 at last check amid news that peer Eli Lilly (LLY) will buy the company for $10.50 per share, or roughly $1.3 billion.

Tesla told staff it plans to pause Cybertruck and Model Y production during the July 4 week. The pause would enable the automaker to perform maintenance on production lines, Tesla told staff.